Comparative Pharmacology
Head-to-head clinical analysis: BENYLIN versus CHILDREN S ZYRTEC HIVES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENYLIN versus CHILDREN S ZYRTEC HIVES.
BENYLIN vs CHILDREN'S ZYRTEC HIVES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
BENYLIN (diphenhydramine) is a first-generation antihistamine that competitively antagonizes histamine at H1 receptors, thereby alleviating allergic symptoms. It also crosses the blood-brain barrier and acts as a central nervous system depressant via inhibition of histamine and acetylcholine, producing sedative, antiemetic, and antitussive effects.
Cetirizine is a selective antagonist of peripheral histamine H1 receptors, inhibiting histamine-mediated allergic reactions.
Oral: 10-20 mL (25-50 mg diphenhydramine) every 4-6 hours; maximum 100 mg per day.
5 mg or 10 mg orally once daily; maximum 10 mg/day.
None Documented
None Documented
Terminal elimination half-life: 4-6 hours in adults; extended to 10-12 hours in hepatic impairment, increasing risk of accumulation.
Terminal elimination half-life is approximately 8-11 hours in healthy adults, allowing twice-daily dosing.
Renal: ~80% as unchanged drug and glucuronide conjugates; fecal/biliary: ~20%.
Cetirizine is primarily excreted renally (~60% unchanged), with ~10% fecal excretion.
Category C
Category C
Antihistamine
Antihistamine